S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

09/20/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Robert Howard Glassman

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Pharvaris NV (NASDAQ:PHVS)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Pharvaris NV Charts.

Pharvaris NV (NASDAQ:PHVS)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Pharvaris NV Charts.

Pharvaris NV News

Form 144 - Report of proposed sale of securities
Thursday 31 October 2024 (1 week ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 24 October 2024 (2 weeks ago) • Edgar (US Regulatory)

Pharvaris Presents Clinical and Non-Clinical Data Supporting HAE Development Program at the 2024 ACAAI Annual Scientific Meeting
Thursday 24 October 2024 (2 weeks ago) • GlobeNewswire Inc.

Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at Upcoming Scientific Meetings
Wednesday 16 October 2024 (4 weeks ago) • GlobeNewswire Inc.

Pharvaris to Host Virtual Investor Event on October 23, 2024
Tuesday 15 October 2024 (4 weeks ago) • GlobeNewswire Inc.

Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at the 2024 HAEi Global Leadership Workshop
Thursday 3 October 2024 (1 month ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 25 September 2024 (1 month ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 23 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 20 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 19 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 19 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 19 September 2024 (2 months ago) • Edgar (US Regulatory)

More Pharvaris NV News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions